UCT Endowment

UCT Endowment

The UCT Endowment was established in 1829 alongside the university itself. Norman Arendse leads the council that sets investment policy. The endowment follows a Responsible and Sustainable Investment Policy that channels capital into bursaries, research chairs and campus infrastructure. Asset allocation includes direct ownership of student residences such as Obz Square and Avenue Road, the GSB Conference Centre, Breakwater Lodge and the Irma Stern Museum. Equity holdings run through the UCT Evergreen Fund and University Technology Fund in Cape Bio Pharms, Strait Access Technologies, CapeRay Medical, C Star and HYENA. All positions sit in South Africa with limited exposure to Mauritius structures. External managers Allan Gray, Coronation Fund Managers and BlackRock handle listed equity sleeves. The endowment lists 901 million USD in assets. It maintains no disclosed headcount for investment staff. Adjacent vehicles include the UCT Foundation and the UCT Trust (UK) established in 1991. May 2024: Attended the Distinguishing UCT Campaign Showcase focused on endowment growth. The endowment operates through a hybrid model that combines direct real-asset ownership with co-investments alongside the University Technology Fund in deep-tech spin-offs. Governance sits with the UCT Council and the independent UCT Foundation trust, separating permanent capital from operating budgets of the university.